SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011812
Filing Date
2021-08-16
Accepted
2021-08-16 16:14:56
Documents
106
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20210630x10q.htm   iXBRL 10-Q 4492746
2 EX-10.1 fbio-20210630xex10d1.htm EX-10.1 826803
3 EX-10.2 fbio-20210630xex10d2.htm EX-10.2 430108
4 EX-10.3 fbio-20210630xex10d3.htm EX-10.3 589402
5 EX-31.1 fbio-20210630xex31d1.htm EX-31.1 13871
6 EX-31.2 fbio-20210630xex31d2.htm EX-31.2 14573
7 EX-32.1 fbio-20210630xex32d1.htm EX-32.1 8233
8 EX-32.2 fbio-20210630xex32d2.htm EX-32.2 8189
  Complete submission text file 0001558370-21-011812.txt   18663561

Data Files

Seq Description Document Type Size
9 EX-101.SCH fbio-20210630.xsd EX-101.SCH 101726
10 EX-101.CAL fbio-20210630_cal.xml EX-101.CAL 88280
11 EX-101.DEF fbio-20210630_def.xml EX-101.DEF 437108
12 EX-101.LAB fbio-20210630_lab.xml EX-101.LAB 645185
13 EX-101.PRE fbio-20210630_pre.xml EX-101.PRE 668730
14 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20210630x10q_htm.xml XML 3710147
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 211178362
SIC: 2834 Pharmaceutical Preparations